Prostaglandin endoperoxide synthase: structure and catalysis.
about
Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated proteinChemistry and antihypertensive effects of tempol and other nitroxidesCarbocations in the synthesis of prostaglandins by the cyclooxygenase of PGH synthase? A radical departure!Insights into the prostanoid pathway in the ovary development of the penaeid shrimp Penaeus monodonThe basis of prostaglandin synthesis in coral: molecular cloning and expression of a cyclooxygenase from the Arctic soft coral Gersemia fruticosaCatalytic properties of rice alpha-oxygenase. A comparison with mammalian prostaglandin H synthasesClinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumoursBiological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human plateletA three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsCREB-dependent cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression is mediated by protein kinase C and calciumGastroprotective mechanism of Paederia foetida Linn. (Rubiaceae)--a popular edible plant used by the tribal community of North-East India.Prostaglandin H synthase. Inactivation of the enzyme in the course of catalysis is accompanied by fast and dramatic changes in protein structure.Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolyticaG-protein coupled receptor-evoked glutamate exocytosis from astrocytes: role of prostaglandins.Identification of a lipoxygenase inhibitor in A431 cells as a phospholipid hydroperoxide glutathione peroxidase.Inhibitory effects of eutigosides isolated from Eurya emarginata on the inflammatory mediators in RAW264.7 cells.Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoidsReactions of prostaglandin endoperoxide synthase with nitric oxide and peroxynitrite.The cyclooxygenase-2 inhibitors: safety and effectiveness.Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress.Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z, 13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COX-1 does not synthesize 15-(R)-hete.Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination.Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.Inhibitors of platelet signal transduction as anti-aggregatory drugs.Pharmacologic considerations in the treatment of injured athletes with nonsteroidal anti-inflammatory drugs.Dual effect of nitric oxide on uterine prostaglandin synthesis in a murine model of preterm labourPurification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a novel hemoprotein.Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases.Dioscorea japonica extract down-regulates prostaglandin E2 synthetic pathway and induces apoptosis in lung cancer cells.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.A protein radical and ferryl intermediates are generated by linoleate diol synthase, a ferric hemeprotein with dioxygenase and hydroperoxide isomerase activities.Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells.Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinaseThe induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMPGene therapy for vascular diseases.Characterization of SfmD as a Heme peroxidase that catalyzes the regioselective hydroxylation of 3-methyltyrosine to 3-hydroxy-5-methyltyrosine in saframycin A biosynthesis.Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.
P2860
Q24604296-DFFA4CB9-9C02-4C09-BF25-D938D19CC457Q24658069-EE2DC0AC-E9FE-45D0-9F5D-D47904716068Q24672649-A3259469-46DA-45B5-9E4D-039940990ED4Q27304443-02B2B5E1-59EB-417E-AA88-32C1669065F3Q28174723-2AEE69FE-D222-44DD-923E-E8EE77DCF213Q28192604-54089098-B531-44FD-918C-15DE5F2F3376Q28209267-025F199D-EE10-4B10-82AE-5A8C10731AD0Q28326819-A5D2A91A-F83D-4328-AB51-A6EFA8E3C741Q28344403-693FFECC-8FEF-4657-B8B1-04B56B57176EQ28567112-A74C06B3-E8C8-415E-AEE3-B74FF4ECCE1EQ30387731-B60A0822-984E-4928-92C0-CD409CEE2EF0Q30422855-F03C6B19-C36F-4ED9-8766-2FBB8A3EC585Q30449610-E6D24578-EC5F-4D48-AD18-7FE2251188EEQ30570942-22C13FEC-6873-4D74-B07F-F0FD69DF5046Q32069125-4BD35B50-3BDC-4049-8B20-CB09DF7EDF55Q33229328-24D53CA9-E71A-4413-B4A4-E1E26C85ABF3Q33433330-B5A0CF8B-7946-4515-B6DD-E7A647A6129EQ33538243-1EA59AA0-1692-4355-B4FC-8010D3D2B723Q33735395-5D642352-581D-4748-8A38-2D124057C9D2Q33835401-A6809ED8-41B2-41F9-82AB-B4231881887CQ33891522-94239279-6FA9-4D6E-ADDD-92B4FD92FFA6Q34188046-9120F545-1042-479C-AD3B-DB4720EAB5F9Q34211740-7DACBFBB-A424-41C8-85C5-646A55AC8D80Q34232030-AF34F5C8-7FBF-4889-A6B7-D5B967550FE3Q34240175-239D4145-4FB2-4A9A-B986-A4620C96F108Q34356115-CC4E4E92-D267-4CE2-8236-95575D40C542Q34384336-2729B12F-502F-495B-B074-DAD6105EA7FEQ34478086-CD9FBA38-B17F-4145-9BF4-A4AACBD430C3Q34489929-A2D7D1EE-358A-49B7-801F-DF307937D5C2Q34536091-C1FB0BD9-5A6A-4652-A192-87F329006E76Q34750251-76842F97-2442-42F1-BB6B-F784D2B0FF6DQ34786073-B89AC0BB-6638-4C19-9A2F-F1EB470FC6EEQ34793764-667C65C8-C634-4BC1-9F92-22C93B9EE198Q35055194-F4C3D6B3-F196-455D-8EF4-22140F35E5BEQ35376020-97A16C72-775F-4245-8656-7F7984FA6CB6Q35609405-3C81CEA4-66BE-4E33-B0CB-5C665FC20E2AQ35609795-420BD207-4DA4-4AED-8452-5380869BBDC5Q35652189-4DC6466E-EE47-44C1-9C03-4B154F2984BEQ35763077-1CF7C2FC-E440-46EA-B528-5CD227F01123Q35763802-D01D5F7C-B4B0-4674-B7FC-95109BA33994
P2860
Prostaglandin endoperoxide synthase: structure and catalysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostaglandin endoperoxide synthase: structure and catalysis.
@en
Prostaglandin endoperoxide synthase: structure and catalysis.
@nl
type
label
Prostaglandin endoperoxide synthase: structure and catalysis.
@en
Prostaglandin endoperoxide synthase: structure and catalysis.
@nl
prefLabel
Prostaglandin endoperoxide synthase: structure and catalysis.
@en
Prostaglandin endoperoxide synthase: structure and catalysis.
@nl
P1476
Prostaglandin endoperoxide synthase: structure and catalysis.
@en
P2093
L J Marnett
P356
10.1016/0005-2760(91)90119-3
P407
P577
1991-04-01T00:00:00Z